MEDICREA: Sales – 1st Quarter Of 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The MEDICREA group (Paris:ALMED) (FR0004178572-ALMED), listed on Alternext Paris and eligible for PEA-PME SME equity savings plans, a company that specializes in the development of innovative surgical technologies for the treatment of spinal pathologies, announces its sales for its 1st quarter to March 31st 2014.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC